Thirteen experts in their fields will collaborate with nine colleges, schools or institutes at Texas A&M.

Merck Foundation launches $22 million cardiac care collaborative. The philanthropic arm of its namesake pharmaceutical giant will work with 11 healthcare partners across the United States to expand ac...

'With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough,' writes Johns Hopkins expert Jeff Coller in a 'Wall Street Journal' op-e...

For more than half a century, Johns Hopkins has been a leader in converting federal support into tangible benefits for the American people—such as correcting maps of the human genome.

Many Americans are set to see huge increases in their health insurance costs, although some will be more affected than others.

Winners of the university's Catalyst and Discovery awards were honored on Oct. 23 as JHU recognized promising early-career faculty and cross-divisional research teams

Companies that make DNA for science labs screen out any requests for dangerous bits of genetic material. But a new study shows how AI could help malevolent actors get the stuff anyway.

James Bellingham. PhD, shares his work.

Patients who got shots of mRNA before starting a type of cancer immunotherapy lived much longer

Drawing on decades of experience in global health and international scientific exchanges, Nobel laureate Peter Agre makes the case that evidence and collaboration—even simply forging friendships...

The Earth BioGenome Project aims to sequence 1.8 million species. It's one of the most ambitious science projects ever, and it will revolutionize biology

The Hopkins team’s new, open-source software dramatically improves scientists’ ability to detect genetic modifications that control gene activity.

Cancer researcher Chi Van Dang studies pharmacokinetics—the way the body absorbs, distributes, metabolizes, and excretes a drug at different times of day. His work on treatment timing holds prom...

The lack of reliable coating methods for amorphous zeolitic imidazolate framework (aZIF) materials hinders their development for applications such as photolithography and separation membranes. Supported by computational fluid dynamics modeling, the authors develop a spin-coating technique to deposit aZIF films from dilute precursors and demonstrate their wafer-scale use in advanced lithographic processes.

NTx appoints RNA biology pioneer Dr. Jeff Coller to its Scientific Advisory Board to advance RNA-based therapeutic platforms.

Robot-assisted surgery, an app for diagnosing strep throat, and a tool to detect glaucoma are all on the health care horizon thanks to AI innovators at Hopkins

In this OxCAN blog, Dr Daniel M Kammen, Bloomberg Distinguished Professor of Energy and Climate Justice at Johns Hopkins University and Fellow at the University of Oxford’s Institute for New Economic ...

What will robots discover as they gather life-supporting data and resources from the depths of Earth's oceans to the reaches of deep space?Below the waves, the ocean remains a largely undiscovered rea...

WASHINGTON, DC –